NCT04806373View on ClinicalTrials.gov

Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

December 14, 2023

Study Completion Date

December 14, 2023

Conditions
Pleural Effusion
Interventions
DRUG

Cathflo Activase

Cathflo Activase 4mg in 50ml normal saline given through chest pleural catheter

DRUG

Talc Slurry Pleurodesis

Talc, 5 gm in 50 ml Normal Saline given through chest pleural catheter

Trial Locations (1)

33021

Memorial Healthcare System, Hollywood

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Memorial Healthcare System

OTHER